Sosei Heptares (the corporate brand of Sosei Group Corporation) is a research-focused biotechnology group, publicly listed in Japan (TSE: 4565) and with sites in Tokyo, London and Cambridge (UK).
Their mission is to make a significant contribution to improving the quality of life and health of people around the world. To achieve this, they discover, design and develop the most innovative and effective medicines for patients worldwide, through world-leading patent-protected technology and platform.
About the Role
Sosei Heptares is now seeking a membrane protein biochemist to join the Biochemistry group at their research facility on Granta Park, Cambridge, UK, working on membrane protein biochemical characterisation to enable drug discovery efforts.
Sosei Heptares are equipped with state-of-the-art protein expression, purification, SPR, mass-spectrometry, crystallisation and cryoEM facilities. Applicants should have experience in the expression and purification of challenging membrane proteins destined for biochemical, biophysical and structural studies. Applicants with a proven track record of publications related to the expression, purification, and biochemical characterisation of difficult membrane protein targets in peer-reviewed journals would be advantageous.
This is an exceptional opportunity to participate in pioneering science with an industry-leading drug discovery company. The successful candidate is expected to:
Applications should include your curriculum vitae and covering letter, providing a short description of the background to your interest in the role, with your application in pdf format, quoting reference number 2021-RS-1BMS.
The closing date for applications is 31st December 2021